{"title": "Recent Publications | Krammer Laboratory", "author": "Moritzky SA; Richards KA; Glover MA; Krammer F; Chaves FA; Topham DJ; Branche A; Nayak JL; Sant AJ", "url": "https://labs.icahn.mssm.edu/krammerlab/recent-publications/", "hostname": "mssm.edu", "description": "2022 Publications Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients.Aleman A, Van Oekelen O, Upadhyaya B, Beach K, Kogan Zajdman A, Alshammary H, Serebryakova K, Agte S, Kappes K, Gleason CR, Srivastava K; PVI/MM/Seronet Study Group, Almo S, Cordon-Cardo C, Krammer F, Merad M, Jagannath S, [...]", "sitename": "Krammer Laboratory |", "date": "2015-04-02", "cleaned_text": "immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients.](https://pubmed.ncbi.nlm.nih.gov/35390296/)Cancer by infected of Velogenic Avian Paramyxoviruses in Rock Doves City, New York.](https://pubmed.ncbi.nlm.nih.gov/35357204/)Microbiol Spectr. 2022 [mRNA-1273 and elicit Transl and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a effect of pre-existing immunity on influenza vaccine responses transcends the impact of vaccine formulation type and vaccination history.](https://pubmed.ncbi.nlm.nih.gov/35199825/) [Sustained Antibody-Dependent NK Cell Functions in recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase [Impacts of rapid mass vaccination against SARS-CoV2 in an early variant of Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig Model.](https://pubmed.ncbi.nlm.nih.gov/34669506/)J [Vaccination with SARS-CoV-2 variants of concern differ between infection and vaccination. ](https://pubmed.ncbi.nlm.nih.gov/34891165/)Clin Infect Dis. 2021 Dec priming local lung-resident B cell Rev Immunol. and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Protein and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. ](https://pubmed.ncbi.nlm.nih.gov/34852217/)Immunity. activity vaccines against ancestral and variant SARS-CoV-2 strains. ](https://pubmed.ncbi.nlm.nih.gov/34846168/) [Development and characterization of a quantitative Delta virus in serum of mRNA-vaccinated patients receiving Tumor Necrosis Factor- inhibitors. ](https://pubmed.ncbi.nlm.nih.gov/34812429/)Med (N Y). 2021 Nov 18. doi: 10.1016/j.medj.2021.11.004. Online ahead of print.PMID: 34812429 [A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model. ](https://pubmed.ncbi.nlm.nih.gov/34809451/)mBio. 2021 Nov 23:e0224121. doi: 10.1128/mBio.02241-21. Online [SARS-CoV-2 during pregnancy and associated outcomes: Results from an ongoing prospective cohort. ](https://pubmed.ncbi.nlm.nih.gov/34806193/)Paediatr Perinat Epidemiol. print.PMID: 34806193 [Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages. ](https://pubmed.ncbi.nlm.nih.gov/34805790/)iScience. determine hemagglutinin-specific CD4 T cell and IgG response following [A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses. ](https://pubmed.ncbi.nlm.nih.gov/34707161/) [Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma. ](https://pubmed.ncbi.nlm.nih.gov/34706273/) [Immunity elicited by natural infection or Ad26.COV2.S hamsters against SARS-CoV-2 variants Virus Neutralization. ](https://pubmed.ncbi.nlm.nih.gov/34704832/) [Longitudinal humoral antibody response to SARS-CoV-2 infection among healthcare workers in a New York City hospital. ](https://pubmed.ncbi.nlm.nih.gov/34702729/) [Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus. ](https://pubmed.ncbi.nlm.nih.gov/34697321/) [Evidence for retained spike-binding and neutralizing activity against emerging COVID-19 mRNA vaccine recipients. ](https://pubmed.ncbi.nlm.nih.gov/34688034/) [Human anti-neuraminidase antibodies reduce airborne transmission of clinical influenza virus isolates in the guinea pig model. ](https://pubmed.ncbi.nlm.nih.gov/34669506/) [Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, subunit influenza A stress with host protein synthesis shutoff. ](https://pubmed.ncbi.nlm.nih.gov/34479996/)Proc Natl Acad Sci activity vaccines against responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity. ](https://pubmed.ncbi.nlm.nih.gov/34462740/)Res Sq. 2021 Aug 26:rs.3.rs-802084. doi: 10.21203/rs.3.rs-802084/v1. Preprint.PMID: Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination. ](https://pubmed.ncbi.nlm.nih.gov/34451971/)Vaccines a high prevalence group of adults and children-implications for community infection control. ](https://pubmed.ncbi.nlm.nih.gov/34425179/)Am J Infect Control. 2021 of Vaccine Broad models. ](https://pubmed.ncbi.nlm.nih.gov/34315826/)Sci Transl neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect In Vivo in a Mouse Model in a Neutralization-Dependent Manner. ](https://pubmed.ncbi.nlm.nih.gov/34311574/)mBio. [Corrigendum: Sterilizing Immunity against SARS-CoV-2 Infection in Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted doi: 10.1002/anie.202105635.PMID: [Immunologic mechanisms of influenza vaccination administered by microneedle patch from a randomized phase spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma. ](https://pubmed.ncbi.nlm.nih.gov/34242572/)Cancer Cell. 2021 for SARS-CoV-2 vaccines needed. ](https://pubmed.ncbi.nlm.nih.gov/34239135/)Nat Med. 2021 Jul 10.1038/s41591-021-01432-4. Online ahead of print.PMID: 34239135 [SARS-CoV-2 mRNA vaccination diverse S2. ](https://pubmed.ncbi.nlm.nih.gov/34192529/)Cell. doi: 10.1038/s41586-021-03738-2. Online ahead of print.PMID: 34182569 [Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.](https://pubmed.ncbi.nlm.nih.gov/34172783/)Sci Rep. 2021 Jun 25;11(1):13308. doi: 10.1038/s41598-021-92740-9.PMID: 34172783 of print.PMID: 3410752 [Molecular evidence of SARS-CoV-2 in New York before 2021 Jun antibodies targeting vaccines for all but a for COVID-19 survivors. ](https://pubmed.ncbi.nlm.nih.gov/34051441/)EBioMedicine. 2021 May responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with non-neutralizing viral for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive to Selected Epitopes on a Zika Virus Protein Antigen by Nanopatterning.](https://pubmed.ncbi.nlm.nih.gov/33929789/)Adv Healthc of the Stalk Domain of Recombinant Influenza Virus N1 Neuraminidase Enhances Protein Stability and 19;9(4):404. doi: 10.3390/vaccines9040404.PMID: 33921722 [Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained in healthy young adults: a prospective cohort study.](https://pubmed.ncbi.nlm.nih.gov/33865504/)Lancet Respir Med. 10.1016/S2666-5247(21)00068-9. Online coronaviruses and SARS-CoV-2 in community and health care workers.](https://pubmed.ncbi.nlm.nih.gov/33822097/)J Infect Dis. 2021 2:jiab176. doi: 10.1093/infdis/jiab176. Online responses after AS03-adjuvanted H1N1pdm09 vaccine: is dominated by non-neutralizing antibodies that target both the NTD and Mar 19;6(1):40. doi: 10.1038/s41541-021-00299-3.PMID: 33742000 [Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.](https://pubmed.ncbi.nlm.nih.gov/33564749/)Cell Rep Med. spike protein reduces but does not abolish neutralizing activity Risk Among Active Duty Military Members Deployed to a Field Hospital - New York City, April 2020.](https://pubmed.ncbi.nlm.nih.gov/33661864/)MMWR Morb Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in against SARS-CoV-2 following assessed infection.](https://pubmed.ncbi.nlm.nih.gov/33442687/)bioRxiv. 2020 18:2020.11.15.383323. a Standardized Virus Neutralization Assay Allows for Cross-Cohort Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in 33593910 [Identification protection against SARS-CoV-2 in morbidity in obese and aged mice and is neutralized by Going to Be Better Prepared Next Time? ](https://pubmed.ncbi.nlm.nih.gov/33521752/)Med (N Y). 2020 10.1101/2021.01.12.21249683. patients with international Spike.](https://pubmed.ncbi.nlm.nih.gov/33468695/)mBio. Lipid Amphiphile Imidazoquinoline TLR7/8 Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model.](https://pubmed.ncbi.nlm.nih.gov/33440898/)Vaccines (Basel). 2021 Jan 11;9(1):40. doi: 10.3390/vaccines9010040.PMID: 33440898 [Heterologous viral protein interactions within licensed vaccines.](https://pubmed.ncbi.nlm.nih.gov/33420089/)NPJ Vaccines. 2020 Jan 10;5(1):3. doi: 10.1038/s41541-019-0153-1.PMID: 33420089 [Immunological memory to SARS-CoV-2 assessed Spike Dec 15;11(6):e02090-20. doi: 10.1128/mBio.02090-20.PMID: 33323511 [Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans.](https://pubmed.ncbi.nlm.nih.gov/33298562/)Sci Transl Med. 2020 Dec Antibody Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients.](https://pubmed.ncbi.nlm.nih.gov/33294855/)Cell Rep Med. 2020 2020 on a chimeric hemagglutinin stalk-based universal influenza virus vaccine in mice.](https://pubmed.ncbi.nlm.nih.gov/33293159/)Vaccine. [A chimeric universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, Large Nosocomial Influenza A Outbreak Informed by Genomic Epidemiology.](https://pubmed.ncbi.nlm.nih.gov/33252647/)Clin Infect Dis. 2020 Nov of print.PMID: 33252647 [SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.](https://pubmed.ncbi.nlm.nih.gov/33247924/)J Infect Dis. the protein of SARS-CoV-2 as a live virus vaccine in a Cohort Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies.](https://pubmed.ncbi.nlm.nih.gov/33182279/)Vaccines Mice Modified Imidazoquinoline A, Krammer F, Cordon-Cardo C, Amler S, Montecalvo M, Hutton B, Taylor J, McDonough KA. [Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses](https://pubmed.ncbi.nlm.nih.gov/33096040/). Guthmiller JJ, Lan LY, Fern\u00e1ndez-Quintero ML, Han J, Utset HA, Bitar DJ, Hamel NJ, Stovicek O, Li M, C, YQ, Nachbagauer R, Palese P, Coughlan AB, KR, Wilson PC. [In Utero Vertical Transmission of Coronavirus Disease 2019 in a Severely Ill 29-week Preterm Infant](https://pubmed.ncbi.nlm.nih.gov/33094016/). Gupta A, Malhotra Krammer F, Clare CA, Vinod S, Ghaly [COVID-19: Staging of a New Disease](https://pubmed.ncbi.nlm.nih.gov/33086031/). Cordon-Cardo C, Pujadas E, Wajnberg A, Sebra Firpo-Betancourt A, Fowkes M, Sordillo E, Paniz-Mondolfi A, Gregory J, Krammer F, Simon V, Isola L, Soon-Shiong P, Aberg JA, Fuster V, Reich DL. [Comparison of and hACE2 models for L, M, Uccellini MB. [Scientific consensus on the COVID-19 pandemic: we need to act now](https://pubmed.ncbi.nlm.nih.gov/33069277/). Alwan NA, Burgess RA, Ashworth S, Beale R, Bhadelia N, Bogaert D, Dowd J, Eckerle I, Goldman P, Kelly-Irving M, Krammer F, Lipsitch M, McNally A, McKee M, Nouri A, Pimenta D, Priesemann V, Rutter H, Silver J, Sridhar C, G, Ziauddeen H. [Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study](https://pubmed.ncbi.nlm.nih.gov/33015652/). Wajnberg A, Mansour M, Leven A, Baine I, Simon V, Aberg J, Krammer F, Reich D, Cordon-Cardo C. [Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model](https://pubmed.ncbi.nlm.nih.gov/32995785/). Amanat R, Schotsaert M, Sep 17. PMID: 32995785 [Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2](https://pubmed.ncbi.nlm.nih.gov/32995763/). Wilson P, Stamper C, Dugan H, Li L, Asby N, Halfmann P, Guthmiller J, Zheng NY, Huang M, Stovicek O, Wang J, Madariaga ML, Shanmugarajah K, Jansen M, Amanat F, Stewart I, Changrob S, Utset H, Huang J, Nelson C, Dai YN, Hall P, Jedrzejczak R, Joachimiak A, Krammer F, Fremont D, Kawaoka Y. 2020 Sep 25. PMID: 32995763 [Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)](https://pubmed.ncbi.nlm.nih.gov/32991843/). Gruber CN, Patel RS, Trachtman R, Lepow L, Amanat Krammer F, Wilson KM, Onel K, Geanon D, Tuballes K, Patel M, Mouskas K, O'Donnell T, Merritt E, Simons NW, Barcessat V, Del Valle DM, Udondem S, Kang G, Gangadharan S, Ofori-Amanfo G, Laserson U, S, Sep PMID: 32991843 [Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective](https://pubmed.ncbi.nlm.nih.gov/32976769/). Madsen A, Dai YN, McMahon M, Schmitz AJ, Turner JS, Tan J, Lei T, Alsoussi WB, Strohmeier S, Amor M, Mohammed BM, Mudd PA, Simon V, Cox RJ, Fremont DH, Krammer F, Ellebedy AH. 2020 Sep 22. PMID: 32976769 [Inborn errors of type I IFN immunity in patients with life-threatening COVID-19](https://pubmed.ncbi.nlm.nih.gov/32972995/). Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, Ogishi M, Sabli IKD, Hodeib K, Ye J, Bolze A, Bigio B, Yang R, Arias AA, Zhou Q, Zhang Y, Onodi F, Korniotis S, Karpf L, Philippot Q, Chbihi L, WM, Razooky BS, Hoffmann HH, Michailidis E, Moens L, Han Lorenzo L, Bizien Meade P, Neehus AL, Ugurbil AC, Corneau G, Zhang P, Rapaport F, Seeleuthner Y, Manry J, Masson C, Schmitt Y, Schl\u00fcter A, Le Voyer T, Khan T, Li J, Fellay J, Roussel L, Shahrooei M, Alosaimi MF, SZ, F, Al Turki S, Hasanato van Beek D, Biondi A, Bettini Quiros-Roldan E, Rossi C, Oler AJ, Tompkins MF, Alba C, Vandernoot I, Goffard Clinicians; G, B\u00e9ziat V, V, LD, PMID: 32967006 [Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models](https://pubmed.ncbi.nlm.nih.gov/32949997/). Shukla R, Beesetti RK, Poddar A, Batra G, Krammer F, Lim JK, Kale S, Lal AA, Swaminathan S, Khanna N. 2020 Sep 15. PMID: 32949997 [Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice](https://pubmed.ncbi.nlm.nih.gov/32943267/). McMahon M, Strohmeier S, Rajendran M, Capuano C, Ellebedy AH, Wilson PC, Krammer F. 2020 Sep 15. PMID: 32943267 [SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike](https://pubmed.ncbi.nlm.nih.gov/32935099/). Guthmiller JJ, Stovicek O, Wang J, Changrob S, Li P, NY, Utset H, Stamper CT, Dugan HL, Miller WD, Huang M, Dai YN, Hall PD, Jansen M, Shanmugarajah K, Donington JS, Krammer Joachimiak A, Kawaoka Y, Tesic V, Madariaga ML, Wilson PC. 2020 Sep 13. PMID: 32935099 [Convalescent plasma treatment of severe COVID-19: a propensity control study](https://pubmed.ncbi.nlm.nih.gov/32934372/). Liu STH, Lin HM, Baine I, Wajnberg A, Gumprecht JP, Rahman F, Rodriguez D, Tandon P, Bassily-Marcus A, Bander J, Sanky C, Dupper A, Zheng A, Nguyen FT, Amanat F, Stadlbauer D, Altman DR, Chen BK, Krammer F, Mendu DR, Firpo-Betancourt A, Levin 15. PMID: 32934372 [SARS-CoV-2-specific IgA and limited inflammatory cytokines are present in the stool of select patients with I, Gonzalez-Reiche A, Siu S, Tankelevich M, Grinspan L, Dixon RE, Jha D, Krammer F, Bongers S, Faith JJ. 2020 Sep 5. PMID: 32909002 [Characterization of novel cross-reactive influenza B virus hemagglutinin head specific antibodies that lack hemagglutinin inhibition activity.](https://pubmed.ncbi.nlm.nih.gov/32907980/) Kirkpatrick E, Henry C, McMahon M, Jiang K, Strohmeier S, van Bakel H, Wilson PC, Krammer F. 2020 Sep 9. PMID: 32907980 [Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak](https://pubmed.ncbi.nlm.nih.gov/32873791/). Dingens AS, Crawford KHD, Adler A, Steele SL, Lacombe K, Eguia R, Amanat F, Walls AC, Wolf CR, Murphy M, Pettie D, Carter L, Qin X, King NP, Veesler D, Krammer F, Dickerson JA, Chu HY, Englund JD. 2020 Sep 1. PMID: 32873791 [Human germinal centres engage memory and naive B cells after influenza vaccination](https://pubmed.ncbi.nlm.nih.gov/32866963/). Turner JS, Zhou JQ, Han J, Schmitz AJ, Rizk Alsoussi Lei T, Amor KM, Meade P, Strohmeier S, Brent Teefey S, Presti RM, Krammer F, AB, Aug 31. PMID: 32866963 [A High Through-Put Assay For Circulating Antibodies Directed Against The S Protein Of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2)](https://pubmed.ncbi.nlm.nih.gov/32860510/). Weiss S, Klingler J, Hioe D, Bermudez-Gonzalez M, Simon V, F, Zolla-Pazner 2020 Aug 29. PMID: 32860510 [Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera](https://pubmed.ncbi.nlm.nih.gov/32817961/). Oguntuyo KY, Stevens CS, Hung CT, Ikegame S, Acklin JA, Kowdle SS, Carmichael RM, Woolard MD, Zhang H, Duty AJ, Kraus TA, Moran TM, Tortorella D, Lim JK, Gamarnik AV, Hioe CE, Zolla-Pazner S, Ivanov SS, Kamil JP, B. 2020 Aug 15. PMID: 32817961 [Anti-SARS-CoV-2 Spike Antibodies are Stable in Convalescent Plasma when Stored at 4\u00b0 Celsius for at Least 6 Weeks](https://pubmed.ncbi.nlm.nih.gov/32798271/). Stadlbauer D, Baine I, Amanat SA. with Nucleoside-Modified mRNA Vaccines Elicits and Humoral Immune SARS-CoV-2 in Mice](https://pubmed.ncbi.nlm.nih.gov/32783919/). Laczk\u00f3 D, Hogan MJ, Toulmin SA, Hicks P, Lederer K, Gaudette BT, Casta\u00f1o D, Amanat F, Muramatsu H, Oguin TH 3rd, Ojha A, Zhang L, Mu Z, Parks R, Manzoni TB, Roper B, Strohmeier S, Tomb\u00e1cz I, Arwood Karik\u00f3 J, Pessaint L, Porto M, Putman-Taylor T, GD, Farzan M, Eisenlohr LC, Weissman D, Krammer F, Bates P, Allman Pardi N. 2020 Jul 30. [A Y, Albrecht RA, S, A, PMID: 32766572 [Newcastle disease virus (NDV) expressing the spike protein SARS-CoV-2 as vaccine candidate](https://pubmed.ncbi.nlm.nih.gov/32743571/). Sun W, Leist SR, McCroskery S, Liu Y, Slamanig S, Oliva J, Amanat F, Schaefer A, Dinnon K, Garcia-Sastre A, Krammer F, RS, Palese P. 2020 Jul 26. PMID: 32743571 [Surveillance of European Domestic Pig Populations Identifies an Emerging Reservoir of Potentially Zoonotic Swine Influenza A Viruses](https://pubmed.ncbi.nlm.nih.gov/32721380/). Henritzi D, Petric Strebelow V, Krammer F, S, Pesch S, Schwemmle M, Beer Ellebedy AH, Zanini F, Artyomov M, Hickman HD, Diamond MS. 2020 Jun 23. PMID: 32699843 [Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)](https://pubmed.ncbi.nlm.nih.gov/32676612/). Gruber C, Patel R, Trachman R, Lepow L, Amanat F,Krammer F, Wilson KM, Onel Geanon Tuballes K, Patel M, Mouskas K, Simons N, Barcessat V, Del Valle D, Udondem S, Kang G, Gangadharan S, Ofori-Amanfo G, Rahman A, Kim-Schulze S, Charney A, Gnjatic S, Gelb B, D. PMID: 32676612 [Comparison A, Jul PMID: 32676603 [Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans](https://pubmed.ncbi.nlm.nih.gov/32661157/). Ellebedy AH, Nachbagauer R, Jackson KJL, Dai YN, Han J, Alsoussi WB, Davis CW, Stadlbauer D, Rouphael N, Chromikova V, McCausland M, Chang CY, Cortese M, Bower M, Chennareddy C, Schmitz AJ, Zarnitsyna VI, A, C, Antia R, Mulligan MJ, Ward AB, Fremont DH, Boyd SD, Pulendran B, Krammer F, Ahmed R. 2020 Jul 13. PMID: 32661157 [Monoclonal Antibody Therapy Protects Pharmacologically Immunosuppressed Mice Influenza JS, Case JB, Zhao H, Schmitz AJ, Zhou JQ, Chen RE, Lei T, Rizk Kleinstein SH, Fremont DH, MS, Ellebedy AH. Amanat KM, Miorin Strohmeier S, McMahon M, Meade P, Liu WC, Albrecht RA, Simon V, Martinez-Sobrido L, Moran T, Krammer F. 2020 Sep. PMID: 32585083 [Non-sterilizing, Infection-Permissive With Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Choi Iba\u00f1ez LI, Strohmeier S, Jun 9. PMID: 32582220 [Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.](https://pubmed.ncbi.nlm.nih.gov/32571934/) Imai M, Iwatsuki-Horimoto K, Hatta M, Loeber S, Halfmann PJ, Nakajima N, Watanabe T, Ujie M, Takahashi K, Ito M, Yamada S, Fan S, Chiba S, Kuroda M, Guan L, Takada K, Armbrust T, Balogh A, Furusawa M, Mitsuya H, Krammer F, T, Kawaoka Y. 2020 Jul 14. PMID: 32571934 [Seroconversion in household members of Brokstad KA, Krammer F, Langeland N; Jun 15. PMID: 32553187 [A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Corona virus 2.](https://pubmed.ncbi.nlm.nih.gov/32511609/) Weiss S, Klingler J, Hioe C, Amanat F, Baine Kojic EM, Stoever J, Liu S, Jurczyszak D, Bermudez-Gonzalez M, Simon V, Krammer F, Zolla-Pazner S. 2020 Apr 17. PMID: 32511609 [Seroprevalence of SARS-CoV-2 among children visiting a hospital during the initial Seattle outbreak](https://pubmed.ncbi.nlm.nih.gov/32511483/). Dingens AS, Crawford KH, Adler A, Steele SL, Lacombe K, Eguia R, Amanat F, Walls AC, Wolf CR, Murphy M, Pettie D, Carter L, Qin X, King NP, Veesler D, Krammer F, Chu HY, Englund JA, Bloom JD. 2020 May Mallajosyula V, Xie J, Buffone C, Kathale N, Providenza S, Jagannathan P, Andrews JR, Blish CA, Krammer F, Dugan H, Wilson PC, Pham TD, Boyd SD, Zhang S, Taubenberger JK, Morales T, Schapiro JM, Parsonnet J, D, Strohmeier S, THO, Chromikova V, McMahon M, Jiang K, Asthagiri Arunkumar G, Jurczyszak Polanco Felgner Moran T, Garcia-Sastre A, Cheng A, Kedzierska K, Vapalahti O, Hepojoki JM, PMID: [Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals](https://pubmed.ncbi.nlm.nih.gov/32493826/?from_term=Krammer+F%5BAuthor%5D&from_sort=date&from_size=20&from_pos=1). Zheng A, Sun W, Xiong X, Freyn AW, Peukes J, Stromeier S, Nachbagauer R, Briggs JAG, F, Palese P. 2020 Jun 3. PMID: 32493826 [Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans With COVID-19 Disease and Unexposed Individuals](https://pubmed.ncbi.nlm.nih.gov/32473127/?from_term=Krammer+F%5BAuthor%5D&from_sort=date&from_size=20&from_pos=2). Grifoni A, Weiskopf D, Ramirez SI, Mateus Moderbacher CR, Rawlings SA, Sutherland A, Premkumar L, Jadi D, de Silva AM, Frazier A, Carlin AF, Greenbaum JA, Peters B, Krammer F, Smith DM, S, Sette A. 2020 May 20. PMID: 32473127 [Introductions and Early Spread of SARS-CoV-2 in the New York City Area](https://pubmed.ncbi.nlm.nih.gov/32471856/?from_term=Krammer+F%5BAuthor%5D&from_sort=date&from_size=20&from_pos=3). Gonzalez-Reiche AS, Hernandez MM, Sullivan MJ, Ciferri Obla A, Fabre S, Kleiner Polanco J, Khan Z, Alburquerque B, van de Guchte A, Dutta J, Francoeur BS, SH, Wang YC, Twyman K, Kasarskis A, Altman DR, Smith M, Sebra R, Aberg J, Krammer F, Garc\u00eda-Sastre A, Luksza M, Patel G, Paniz-Mondolfi A, Gitman M, Sordillo EM, Simon V, van Bakel H. 2020 29. PMID: 32471856 [Serology Assays to Manage COVID-19](https://pubmed.ncbi.nlm.nih.gov/32414781/?from_term=Krammer+F%5BAuthor%5D&from_sort=date&from_size=20&from_pos=4). PMID: 32414781 [Asymptomatic Seroconversion of Immunoglobulins Hains DS, Schwaderer AL, Carroll AE, Starr MC, Wilson D, Strohmeier S, Nguyen THO, Chromikova V, McMahon M, Jiang K, Arunkumar GA, Jurczyszak D, Polanco J, Bermudez-Gonzalez C, Felgner PL, Moran T, Garc\u00eda-Sastre A, Cheng AC, Kedzierska K, Vapalahti O, Hepojoki JM, V, Krammer F. R, Guglia AF, Sanchez N, Amanat F, Gresh L, Kuan G, Krammer F, Gordon Jun 2. PMID: 32389495 [A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice](https://pubmed.ncbi.nlm.nih.gov/32359470/?from_term=Krammer+F%5BAuthor%5D&from_sort=date&from_size=20&from_pos=8). Freyn AW, Ramos da Silva J, Rosado VC, Bliss CM, Pine M, Mui BL, Tam de Souza Ferreira Krammer F, Coughlan L, Palese Apr 19. PMID: 32359470 [Zika Virus Envelope Nanoparticle Antibodies Protect Mice Disease Enhancement](https://pubmed.ncbi.nlm.nih.gov/32305868/?from_term=Krammer+F%5BAuthor%5D&from_sort=date&from_size=20&from_pos=9). Shukla Shanmugam Apr. PMID: 32305868 [SARS-CoV-2 Humans: A Detailed Protocol Assay, Antigen Production, and Test Setup](https://pubmed.ncbi.nlm.nih.gov/32302069/?from_term=Krammer+F%5BAuthor%5D&from_sort=date&from_size=20&from_pos=10). Stadlbauer D, Amanat F, Chromikova V, Jiang K, Strohmeier S, Arunkumar GA, Tan J, Bhavsar D, Capuano C, Kirkpatrick E, Meade P, Brito RN, Teo C, McMahon M, Simon V, PMID: 32302069 [SARS-CoV-2 Vaccines: Monoclonal Antibodies Against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect From Virus Challenge in a Preclinical Hamster Model](https://pubmed.ncbi.nlm.nih.gov/32209676/?from_term=Krammer+F%5BAuthor%5D&from_sort=date&from_page=2&from_pos=2). Duehr J, McMahon M, Williamson B, Amanat F, Durbin A, Hawman DW, Noack D, Uhl S, Tan GS, Mar barcoding using a viral hemagglutinin.](https://pubmed.ncbi.nlm.nih.gov/31988118/?from_term=Krammer+F%5BAuthor%5D&from_sort=date&from_pos=1) [Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults.](https://www.ncbi.nlm.nih.gov/pubmed/31964741) Meade P, Kuan G, Strohmeier S, Maier HE, Amanat F, Balmaseda A, Ito K, Kirkpatrick E, Javier A, Gresh L, Nachbagauer R, Gordon A, Krammer F. 2020 Jan 21. PMID:31964741 [Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter correlates with activity Chromikova Tan J, Aslam Ayllon J, Simon V, Garc\u00eda-Sastre A, Salaun B, Nachbagauer R, Krammer F. 2020 Jan 17. PMID:31959425 2019 Publications [Viral Fitness Landscapes in Diverse Host Species Reveal Multiple Evolutionary Lines for the NS1 Gene of Influenza A Viruses.](https://www.ncbi.nlm.nih.gov/pubmed/31851929) Mu\u00f1oz-Moreno V, Lee I, Panis M, Ayll\u00f3n J, Sachs D, Park MS, Krammer F, tenOever BR, Garc\u00eda-Sastre A. 2019 Dec 17. PMID:31851929 [Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts.](https://www.ncbi.nlm.nih.gov/pubmed/31839997) Nachbagauer R, Salaun B, Stadlbauer D, Behzadi [Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines.](https://www.ncbi.nlm.nih.gov/pubmed/31837101) Krammer F, Weir JP, Engelhardt O, Katz JM, Cox RJ. 2019 Dec 13. PMID:31837382 [Monoclonal antibodies with neutralizing activity and Fc-effector functions against the Machupo virus glycoprotein.](https://www.ncbi.nlm.nih.gov/pubmed/31801871) Amanat F, Duehr J, Huang C, Paessler S, Tan G, Krammer F. 2019 Dec 4. PMID:31801871 [Broadly protective human antibodies that target the active site of influenza virus neuraminidase.](https://www.ncbi.nlm.nih.gov/pubmed/31649200) Stadlbauer D, Zhu X, McMahon M, Turner JS, Wohlbold TJ, Schmitz AJ, Strohmeier S, Yu W, Nachbagauer R, Mudd PA, Wilson IA, Ellebedy AH, Krammer F. 2019 Oct 25. PMID:31649200 A full publication list "}